No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study

Detalhes bibliográficos
Autor(a) principal: Giorelli,Guilherme de Vieira
Data de Publicação: 2015
Outros Autores: Matos,Lívia Nascimento de, Saado,Amir, Soibelman,Vera Lúcia, Dias,Cristiane Bitencourt
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802015000200073
Resumo: CONTEXT AND OBJECTIVE:Several studies have evaluated the role of low 25-hydroxyvitamin D (25OHD3) in the pathogenesis of type 2 diabetes (T2DM) and have presented controversial results. The metabolic processes that culminate in T2DM begin under prediabetic conditions. Our aim was to analyze the association between 25OHD3 and glucose metabolism in individuals who were free from but at elevated risk of diabetes.DESIGN AND SETTING:Cross-sectional study at a tertiary hospital.METHODS:Anthropometric and laboratory profiles were determined in patients with one or more of the following risk factors: hypertension; body mass index (BMI) ≥ 25 kg/m2; waist circumference > 80 cm for women and > 94 cm for men; first-degree relatives with diabetes; women with large-for-gestational-age newborns or with gestational T2DM; HDL-cholesterol (high density lipoprotein) < 35 mg/dl; and triglycerides > 250 mg/dl. The patients were divided into two groups: one with prediabetes (abnormal fasting plasma glucose or oral glucose tolerance test) and the other with normal glucose (euglycemic).RESULTS:There was no statistically significant difference between the prediabetic group (n = 38) and euglycemic group (n = 15) regarding age (66.4 ± 10.6 versus 62.6 ± 9.1 years), gender (52.6 versus 73.3% female) and BMI (30.1 ± 4.61 versus 27.9 ± 4.7 kg/m2). Low serum levels of 25OHD3 were found in both groups, without any statistically significant difference between them (29.1 ± 11.8 versus 26.87 ± 9.2 ng/dl).CONCLUSION:There was no association between 25OHD3 levels and the clinical or laboratorial variables analyzed.
id APM-1_1cbb0022fd90d195678203396fc55f50
oai_identifier_str oai:scielo:S1516-31802015000200073
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional studyVitamin DGlucose intolerancePrediabetic stateHyperglycemiaDiabetes mellitusCONTEXT AND OBJECTIVE:Several studies have evaluated the role of low 25-hydroxyvitamin D (25OHD3) in the pathogenesis of type 2 diabetes (T2DM) and have presented controversial results. The metabolic processes that culminate in T2DM begin under prediabetic conditions. Our aim was to analyze the association between 25OHD3 and glucose metabolism in individuals who were free from but at elevated risk of diabetes.DESIGN AND SETTING:Cross-sectional study at a tertiary hospital.METHODS:Anthropometric and laboratory profiles were determined in patients with one or more of the following risk factors: hypertension; body mass index (BMI) ≥ 25 kg/m2; waist circumference > 80 cm for women and > 94 cm for men; first-degree relatives with diabetes; women with large-for-gestational-age newborns or with gestational T2DM; HDL-cholesterol (high density lipoprotein) < 35 mg/dl; and triglycerides > 250 mg/dl. The patients were divided into two groups: one with prediabetes (abnormal fasting plasma glucose or oral glucose tolerance test) and the other with normal glucose (euglycemic).RESULTS:There was no statistically significant difference between the prediabetic group (n = 38) and euglycemic group (n = 15) regarding age (66.4 ± 10.6 versus 62.6 ± 9.1 years), gender (52.6 versus 73.3% female) and BMI (30.1 ± 4.61 versus 27.9 ± 4.7 kg/m2). Low serum levels of 25OHD3 were found in both groups, without any statistically significant difference between them (29.1 ± 11.8 versus 26.87 ± 9.2 ng/dl).CONCLUSION:There was no association between 25OHD3 levels and the clinical or laboratorial variables analyzed.Associação Paulista de Medicina - APM2015-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802015000200073Sao Paulo Medical Journal v.133 n.2 2015reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2013.7180005info:eu-repo/semantics/openAccessGiorelli,Guilherme de VieiraMatos,Lívia Nascimento deSaado,AmirSoibelman,Vera LúciaDias,Cristiane Bitencourteng2015-10-09T00:00:00Zoai:scielo:S1516-31802015000200073Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2015-10-09T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
title No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
spellingShingle No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
Giorelli,Guilherme de Vieira
Vitamin D
Glucose intolerance
Prediabetic state
Hyperglycemia
Diabetes mellitus
title_short No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
title_full No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
title_fullStr No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
title_full_unstemmed No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
title_sort No association between 25-hydroxyvitamin D levels and prediabetes in Brazilian patients. A cross-sectional study
author Giorelli,Guilherme de Vieira
author_facet Giorelli,Guilherme de Vieira
Matos,Lívia Nascimento de
Saado,Amir
Soibelman,Vera Lúcia
Dias,Cristiane Bitencourt
author_role author
author2 Matos,Lívia Nascimento de
Saado,Amir
Soibelman,Vera Lúcia
Dias,Cristiane Bitencourt
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Giorelli,Guilherme de Vieira
Matos,Lívia Nascimento de
Saado,Amir
Soibelman,Vera Lúcia
Dias,Cristiane Bitencourt
dc.subject.por.fl_str_mv Vitamin D
Glucose intolerance
Prediabetic state
Hyperglycemia
Diabetes mellitus
topic Vitamin D
Glucose intolerance
Prediabetic state
Hyperglycemia
Diabetes mellitus
description CONTEXT AND OBJECTIVE:Several studies have evaluated the role of low 25-hydroxyvitamin D (25OHD3) in the pathogenesis of type 2 diabetes (T2DM) and have presented controversial results. The metabolic processes that culminate in T2DM begin under prediabetic conditions. Our aim was to analyze the association between 25OHD3 and glucose metabolism in individuals who were free from but at elevated risk of diabetes.DESIGN AND SETTING:Cross-sectional study at a tertiary hospital.METHODS:Anthropometric and laboratory profiles were determined in patients with one or more of the following risk factors: hypertension; body mass index (BMI) ≥ 25 kg/m2; waist circumference > 80 cm for women and > 94 cm for men; first-degree relatives with diabetes; women with large-for-gestational-age newborns or with gestational T2DM; HDL-cholesterol (high density lipoprotein) < 35 mg/dl; and triglycerides > 250 mg/dl. The patients were divided into two groups: one with prediabetes (abnormal fasting plasma glucose or oral glucose tolerance test) and the other with normal glucose (euglycemic).RESULTS:There was no statistically significant difference between the prediabetic group (n = 38) and euglycemic group (n = 15) regarding age (66.4 ± 10.6 versus 62.6 ± 9.1 years), gender (52.6 versus 73.3% female) and BMI (30.1 ± 4.61 versus 27.9 ± 4.7 kg/m2). Low serum levels of 25OHD3 were found in both groups, without any statistically significant difference between them (29.1 ± 11.8 versus 26.87 ± 9.2 ng/dl).CONCLUSION:There was no association between 25OHD3 levels and the clinical or laboratorial variables analyzed.
publishDate 2015
dc.date.none.fl_str_mv 2015-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802015000200073
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802015000200073
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-3180.2013.7180005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.133 n.2 2015
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209264337944576